Administration officials continue to defend the government's choice to purchase China’s Sinovac Biotech Ltd. vaccine for its national inoculation program amid mounting concerns about the vaccine’s price and efficacy.
Full Post on Source: COVID-19 cases in the Philippines breach 513,000
